Amid its efforts to support biosimilars, the Food and Drug Administration is wading into one of the most hot-button segments of the ongoing national debate over drug pricing: insulin. In a statement ...
The FDA called it “a historic day” as insulin and certain other biologic drugs transitioned to a different regulatory pathway. The 10-year transition built into the Biologics Price Competition and ...
Please provide your email address to receive an email when new articles are posted on . The FDA on Monday announced the formal transition of insulin and certain other biologic drugs to a new ...
LA JOLLA, CA—September 30, 2013¬–A team led by scientists at The Scripps Research Institute (TSRI) has created the first comprehensive roadmap of the protein interactions that enable cells in the ...
As the heat turns up on drug manufacturers who determine the price of insulin and the health insurers and middlemen who determine what patients pay, one company — Cigna's Express Scripts — announced ...
On Sunday in Chicago, Dr. Athena Philis-Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback